# Neurology (epilepsy) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Florence Griffith Joyner (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML033-SYN
- Date: 2026-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rahul Mehta-Sorensen, MD
- Calendar frame: modern shifted

- Requested by: Celeste Vanterpool, MD

## Reason for consultation

Generalized tonic-clonic seizure on a flight two and a half weeks ago in a 36-year-old former Olympic sprinter who still trains daily, with treatment for seizures elsewhere in the past (records requested) and no antiseizure medication now. EEG and MRI of the brain with susceptibility-weighted imaging are booked this week. Please see her within two weeks to interpret them, decide whether this is epilepsy, and advise on treatment and safety. **S**

## History

Ms. Griffith Joyner, 36, is seen at the request of Dr. Vanterpool two weeks after her first visit for a generalized tonic-clonic seizure on a flight. Others described stiffening and then jerking of all four limbs with confusion afterwards; she remembers nothing of it. She has had treatment for seizures elsewhere in the past, and those records have not arrived. There was no provoking factor. She has had no seizure since. She trains most days, flies often for work, and has stopped driving. She is not pregnant and is not planning a pregnancy now. She wants the details kept private. **S**

## Examination

| System | Finding |
|---|---|
| General | Fit and well; weight 61.2 kg; blood pressure 110/68, pulse 58 |
| Neurological | Alert and oriented; smell intact in each nostril; cranial nerves, strength, reflexes, sensation, coordination and gait normal |

BP 110/68 mmHg; pulse 58 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 61.2 kg; BMI 21.2 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Vanterpool's intake note and laboratory results: blood count, electrolytes, glucose, calcium, magnesium, creatinine, ALT and creatine kinase normal; pregnancy test negative. Sleep-deprived EEG: intermittent left frontal sharp waves and focal slowing, maximal at F7 and Fp1; no generalized discharges. MRI of the brain, epilepsy protocol with susceptibility-weighted imaging and gadolinium: a 1.4 cm cavernous malformation in the left orbitofrontal cortex with a complete hemosiderin rim (Zabramski type II), an adjacent developmental venous anomaly, no other lesion, and no acute hemorrhage. PHQ-9: 3. All results are synthetic.

## Assessment

1. **Focal epilepsy with structural cause** (G40.209). The seizure was focal in onset, from the left orbitofrontal cortex, and spread to both hemispheres (focal to bilateral tonic-clonic). The EEG discharges match the site of the cavernous malformation. Under the ILAE 2014 practical definition, one unprovoked seizure with an epileptogenic lesion and matching discharges is epilepsy, because the risk of another seizure exceeds 60%; her earlier seizures add to that. I recommend starting an antiseizure medication now. For a woman who could become pregnant, levetiracetam or lamotrigine carries the lowest risk of birth defects; levetiracetam reaches an effective dose at once and does not interact with hormonal contraception, while lamotrigine needs about six weeks of titration and its level falls with estrogen. Valproate should be avoided. Levetiracetam can cause irritability or low mood, which should be asked about at each visit. She should take folic acid 0.4 mg daily and plan any pregnancy with the epilepsy team. SUDEP should be discussed with her at diagnosis; today's visit did not allow a full discussion, so I have asked that it be the first item at her next primary care visit: SUDEP is uncommon but real, tonic-clonic seizures are the main risk, and freedom from them is the best protection. **S**
2. **Solitary cerebral cavernous malformation, left orbitofrontal** (Q28.3). A single cavernous malformation with a developmental venous anomaly is the sporadic form, so familial genetic testing is not needed. Because it is the source of her epilepsy and lies in accessible cortex, neurosurgical evaluation is recommended: complete removal with the surrounding hemosiderin rim gives a high chance of freedom from seizures, and early surgery is associated with better seizure outcomes than surgery after years of seizures. **S**

## Recommendations

1. Levetiracetam 500 mg twice daily from today, with mood and irritability checked at each visit; switch to lamotrigine if mood effects are troublesome; avoid valproate.
2. Folic acid 0.4 mg daily; contraception and pregnancy planning reviewed at each visit.
3. Neurosurgical evaluation within three weeks for lesionectomy of the cavernous malformation with its hemosiderin rim; continue levetiracetam through and for at least two years after surgery.
4. Seizure diary, written seizure action plan, and emergency services for a seizure lasting five minutes or more.
5. SUDEP counseling as the first item at the next primary care visit, with nocturnal supervision or a wrist-worn seizure detection device.
6. Safety: showers instead of baths, swimming only with a companion who knows first aid, no heights or working alone near water; flying is allowed with medication in hand luggage.
7. Driving only when the California DMV clears her after review of her seizure control; return to training on a graded plan after any surgery.
8. Report sudden severe headache or new neurological symptoms at once, which could mean bleeding from the malformation.

## Strengths and supports

- Married, with a young child; household members are not named and have no role in this record. Supports: her household, her training community, and the young athletes she works with **S**

## Communication

Discussed with Dr. Vanterpool, who saw her the same day. The EEG and MRI images were shown and explained to Ms. Griffith Joyner, who chose to start levetiracetam today and to meet the neurosurgeon; she decides who else receives this note. **S**

## Follow-up

Epilepsy review after the neurosurgical opinion and again after any surgery; Dr. Vanterpool continues primary care and shares the monitoring. **S**

## Guideline basis

- Krumholz A, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology 2015;84(16):1705-1713 (PMID 25901057) (2015), American Academy of Neurology and American Epilepsy Society
- Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55(4):475-482 (PMID 24730690) (2014), International League Against Epilepsy
- Akers A, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80(5):665-680 (PMID 28387823) (2017), Angioma Alliance (Neurosurgery)
- Harden C, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology 2017;88(17):1674-1680 (PMID 28438841) (2017), American Academy of Neurology and American Epilepsy Society
- Pack AM, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology 2024;102(11):e209279 (PMID 38748979) (2024), American Academy of Neurology, American Epilepsy Society and Society for Maternal-Fetal Medicine
- Beniczky S, et al. Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epilepsia 2021;62(3):632-646 (PMID 33666944) (2021), International League Against Epilepsy and International Federation of Clinical Neurophysiology
- Governor's message returning Senate Bill 357 without signature (physician reporting of disorders characterized by lapses of consciousness remains mandatory under Health and Safety Code section 103900) (2024), Office of the Governor of California
